Search research articles
Contact Us
Filters
Showing results (221-230 of 248) with videos related to
Page
of 25
Sort By:
The Cancer Journal From Scientific American
|
August 10, 1999
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial
P J Hesketh, J J Crowley, H A Burris, et al.
Frontiers in Immunology
|
April 27, 2018
<i>In Silico</i> and Structural Analyses Demonstrate That Intrinsic Protein Motions Guide T Cell Receptor Complementarity Determining Region Loop Flexibility
Christopher J Holland, Bruce J MacLachlan, Valentina Bianchi, et al.
Microorganisms
|
June 27, 2020
Cryo-EM Structure and Molecular Dynamics Analysis of the Fluoroquinolone Resistant Mutant of the AcrB Transporter from <i>Salmonella</i>
Rachel M Johnson, Chiara Fais, Mayuriben Parmar, et al.
The New England Journal of Medicine
|
January 23, 1999
Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group
R M Navari, R R Reinhardt, R J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2003
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group
Paul J Hesketh, Steven M Grunberg, Richard J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy
David G Warr, Paul J Hesketh, Richard J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2011
Antiemetics: American Society of Clinical Oncology clinical practice guideline update
Ethan Basch, Ann Alexis Prestrud, Paul J Hesketh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology
R J Gralla, D Osoba, M G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2017
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna, David Johnson, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2020
Antiemetics: ASCO Guideline Update
Paul J Hesketh, Mark G Kris, Ethan Basch, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 248) with videos related to
Sort By:
Page
of 25
The Cancer Journal From Scientific American
|
August 10, 1999
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial
P J Hesketh, J J Crowley, H A Burris, et al.
Frontiers in Immunology
|
April 27, 2018
<i>In Silico</i> and Structural Analyses Demonstrate That Intrinsic Protein Motions Guide T Cell Receptor Complementarity Determining Region Loop Flexibility
Christopher J Holland, Bruce J MacLachlan, Valentina Bianchi, et al.
Microorganisms
|
June 27, 2020
Cryo-EM Structure and Molecular Dynamics Analysis of the Fluoroquinolone Resistant Mutant of the AcrB Transporter from <i>Salmonella</i>
Rachel M Johnson, Chiara Fais, Mayuriben Parmar, et al.
The New England Journal of Medicine
|
January 23, 1999
Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group
R M Navari, R R Reinhardt, R J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2003
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group
Paul J Hesketh, Steven M Grunberg, Richard J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy
David G Warr, Paul J Hesketh, Richard J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2011
Antiemetics: American Society of Clinical Oncology clinical practice guideline update
Ethan Basch, Ann Alexis Prestrud, Paul J Hesketh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology
R J Gralla, D Osoba, M G Kris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2017
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna, David Johnson, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2020
Antiemetics: ASCO Guideline Update
Paul J Hesketh, Mark G Kris, Ethan Basch, et al.
Page
of 25